Search results
3 Magnificent Stocks That Are Passive Income Machines
Motley Fool via Yahoo Finance· 7 days agoWhile AbbVie has been and will almost certainly continue to be a passive income machine, there's...
Zacks Industry Outlook Highlights Mettler-Toledo and Bruker
Zacks via Yahoo Finance· 6 days agoShares of this Zacks Rank #3 (Hold) company have gained 11.4% year to date. Why Haven’t You Looked...
Journey Medical Corporation to Participate in the Alliance Global Partners’ (A.G.P.) Virtual...
Morningstar· 5 days agoSCOTTSDALE, Ariz., May 15, 2024 (GLOBE NEWSWIRE) -- Journey Medical Corporation (“Journey Medical” or “the Company”) (Nasdaq: DERM), a commercial-stage pharmaceutical < ...
Are Medical Stocks Lagging Entera Bio (ENTX) This Year?
Zacks via Yahoo Finance· 5 days agoOn the other hand, Assembly Biosciences belongs to the Medical -Generic Drugs industry. This 13-...
Implied Volatility Surging for Amphastar (AMPH) Stock Options
Zacks via Yahoo Finance· 6 days agoCurrently, Amphastar is a Zacks Rank #3 (Hold) in the Medical - Generic Drugs industry that ranks in...
3 Drug Stocks to Watch on Raised 2024 Earnings & Sales Guidance
Zacks via Yahoo Finance· 5 days agoHere we discuss three drugmakers, Eli Lilly and Company (LLY), Novo Nordisk (NVO) and Merck (MRK),...
Hims & Hers Stock Hits 3-Year High After Announcing $199 Weight-Loss Alternative To Wegovy
Forbes· 23 hours agoShares of telehealth company Hims & Hers Health closed at a three-year high Monday after the company...
Markets News, May 20, 2024: Tech Lifts Nasdaq to Record; JPMorgan Drags Dow Below 40K
Investopedia· 8 hours agoU.S. stocks were mixed on Monday, with tech stocks climbing and the Dow hovering around 40,000, a...
Heard on the Street: Hims Is Jumping on a Crowded Ozempic Bandwagon
The Wall Street Journal· 12 hours agoTelevision viewers are used to being bombarded with savvy ads from Hims & Hers Health for erectile...
Cannabis Meets Prescription Drugs, Steroids And Ketamine In Schedule III: What It Means, Key Stocks...
Benzinga· 3 days agoPresident Joe Biden's administration is moving to reschedule cannabis from Schedule I to Schedule...